布鲁杆菌病是公认的人兽共患病,全世界每年发病约50万例,包括中国在内的许多国家和地区都存在广泛的人、畜间流行。为探索急性期布病最佳治疗方案,我们将“头孢曲松钠+阿奇霉素”和“利福平+多西环素”两个治疗方案进行疗效观察比较。1资料与方法1.1研究对象选取2015年1至12月,在吉林省地方病第一防治研究所门诊根据《布鲁杆菌病诊断标准》WS 269-2007首次确诊的急性期布病病例;年龄 Brucellosis is recognized as zoonosis, with an annual incidence of about 500,000 cases in the world. There are a wide range of people and livestock epidemics in many countries and regions, including China. In order to explore the best treatment plan for acute IBD, we compared the therapeutic effects of “ceftriaxone + azithromycin” and “rifampin + doxycycline”. 1 Materials and Methods 1.1 Subjects Selected from January to December 2015, the first case of acute brucellosis diagnosed according to the diagnostic criteria of brucellosis WS 269-2007 at the First Institute for Prevention and Treatment of Endemic Diseases in Jilin Province; the age